(Q39379250)

11 September 2017

title

Comparison of the effects of marchantin C and fucoidan on sFlt-1 and angiogenesis in glioma microenvironment (English)

1 reference

11 September 2017

Yafeng Lv

1

1 reference

11 September 2017

Qingxu Song

2

1 reference

11 September 2017

Qianqian Shao

3

1 reference

11 September 2017

Wenjuan Gao

4

1 reference

11 September 2017

Haiting Mao

5

1 reference

11 September 2017

Hongxiang Lou

6

1 reference

11 September 2017

Xun Qu

7

1 reference

11 September 2017

Xingang Li

8

1 reference

11 September 2017

publication date

7 February 2012

1 reference

Journal of Pharmacy and Pharmacology

11 September 2017

published in

1 reference

11 September 2017

volume

64

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

604-609

1 reference

Epidemiology of brain tumors.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Vascular endothelial growth factor and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

VEGF inhibition and renal thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Angiogenesis and antiangiogenic therapy for malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Antifungal bis[bibenzyls] from the Chinese liverwort Marchantia polymorpha L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Marchantin C, a macrocyclic bisbibenzyl, induces apoptosis of human glioma A172 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Marchantin C: a potential anti-invasion agent in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Structure of a fucoidan from the brown seaweed Fucus evanescens C.Ag

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Fucoidan: structure and bioactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

Suppression of iNOS expression by fucoidan is mediated by regulation of p38 MAPK, JAK/STAT, AP-1 and IRF-1, and depends on up-regulation of scavenger receptor B1 expression in TNF-alpha- and IFN-gamma-stimulated C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01430.X

10.1111/J.2042-7158.2011.01430.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference